578 related articles for article (PubMed ID: 23421098)
1. [Marihuana and cannobinoids as medicaments].
Tkaczyk M; Florek E; Piekoszewski W
Przegl Lek; 2012; 69(10):1095-7. PubMed ID: 23421098
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
Rice J; Cameron M
Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic potential of cannabis and cannabinoids.
Grotenhermen F; Müller-Vahl K
Dtsch Arztebl Int; 2012 Jul; 109(29-30):495-501. PubMed ID: 23008748
[TBL] [Abstract][Full Text] [Related]
4. Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation.
Krcevski-Skvarc N; Wells C; Häuser W
Eur J Pain; 2018 Mar; 22(3):440-454. PubMed ID: 29134767
[TBL] [Abstract][Full Text] [Related]
5. Sativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain.
Barnes MP
Expert Opin Pharmacother; 2006 Apr; 7(5):607-15. PubMed ID: 16553576
[TBL] [Abstract][Full Text] [Related]
6. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
Pertwee RG
Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoids in clinical practice.
Williamson EM; Evans FJ
Drugs; 2000 Dec; 60(6):1303-14. PubMed ID: 11152013
[TBL] [Abstract][Full Text] [Related]
8. Combined cannabinoid therapy via an oromucosal spray.
Perez J
Drugs Today (Barc); 2006 Aug; 42(8):495-503. PubMed ID: 16969427
[TBL] [Abstract][Full Text] [Related]
9. Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature.
Inglet S; Winter B; Yost SE; Entringer S; Lian A; Biksacky M; Pitt RD; Mortensen W
Ann Pharmacother; 2020 Nov; 54(11):1109-1143. PubMed ID: 32483988
[TBL] [Abstract][Full Text] [Related]
10. [Potential applications of marijuana and cannabinoids in medicine].
Zdrojewicz Z; Pypno D; Cabała K; Bugaj B; Waracki M
Pol Merkur Lekarski; 2014 Oct; 37(220):248-52. PubMed ID: 25518584
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic use of cannabis derivatives].
Benyamina A; Reynaud M
Rev Prat; 2014 Feb; 64(2):165-8. PubMed ID: 24701869
[TBL] [Abstract][Full Text] [Related]
12. [News about therapeutic use of Cannabis and endocannabinoid system].
Duran M; Laporte JR; Capellà D
Med Clin (Barc); 2004 Mar; 122(10):390-8. PubMed ID: 15033046
[TBL] [Abstract][Full Text] [Related]
13. Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis.
Centonze D; Mori F; Koch G; Buttari F; Codecà C; Rossi S; Cencioni MT; Bari M; Fiore S; Bernardi G; Battistini L; Maccarrone M
Neurol Sci; 2009 Dec; 30(6):531-4. PubMed ID: 19768368
[TBL] [Abstract][Full Text] [Related]
14. The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews.
Nielsen S; Germanos R; Weier M; Pollard J; Degenhardt L; Hall W; Buckley N; Farrell M
Curr Neurol Neurosci Rep; 2018 Feb; 18(2):8. PubMed ID: 29442178
[TBL] [Abstract][Full Text] [Related]
15. Sativex(®) (tetrahydrocannabinol + cannabidiol), an endocannabinoid system modulator: basic features and main clinical data.
Vermersch P
Expert Rev Neurother; 2011 Apr; 11(4 Suppl):15-9. PubMed ID: 21449855
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of cannabinoids in CNS disease.
Croxford JL
CNS Drugs; 2003; 17(3):179-202. PubMed ID: 12617697
[TBL] [Abstract][Full Text] [Related]
17. Emerging role of cannabinoids and synthetic cannabinoid receptor 1/cannabinoid receptor 2 receptor agonists in cancer treatment and chemotherapy-associated cancer management.
Shah SA; Gupta AS; Kumar P
J Cancer Res Ther; 2021; 17(1):1-9. PubMed ID: 33723124
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.
Smith PF
Curr Opin Investig Drugs; 2002 Jun; 3(6):859-64. PubMed ID: 12137404
[TBL] [Abstract][Full Text] [Related]
19. Symptomatic treatment of multiple sclerosis using cannabinoids: recent advances.
Smith PF
Expert Rev Neurother; 2007 Sep; 7(9):1157-63. PubMed ID: 17868014
[TBL] [Abstract][Full Text] [Related]
20. Sativex for the management of multiple sclerosis symptoms.
Perras C
Issues Emerg Health Technol; 2005 Sep; (72):1-4. PubMed ID: 16317825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
